ClinicalTrials.gov record
Active, not recruiting Phase 1Phase 2 Interventional

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema

ClinicalTrials.gov ID: NCT06850922

Public ClinicalTrials.gov record NCT06850922. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 4:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Patients With Diabetic Macular Edema

Study identification

NCT ID
NCT06850922
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
546 participants

Conditions and interventions

Interventions

  • Aflibercept Drug
  • Faricimab Drug
  • RO7446603 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 21, 2022
Primary completion
Apr 29, 2027
Completion
Apr 29, 2027
Last update posted
Apr 26, 2026

2022 – 2027

United States locations

U.S. sites
69
U.S. states
24
U.S. cities
62
Facility City State ZIP Site status
Arizona Retina and Vitreous Consultants Phoenix Arizona 85020-5917
Associated Retinal Consultants PC Phoenix Arizona 85020
Retinal Research Institute, LLC Phoenix Arizona 85053
Retinal Diagnostic Center Campbell California 95008
Retina Consultants of Orange County Fullerton California 92835
Retinal Consultants Medical Group Modesto California 95356-9412
Northern California Retina-Vitreous Associates Mountain View California 94040
Retinal Consultants Medical Group Sacramento California 95825
University of California San Francisco San Francisco California 94158
Macula Retina Vitreous Research Institute Torrance California 90503-3270
Bay Area Retina Associates;Study Department Walnut Creek California 94598
University of Colorado - Eye Center - PPDS Aurora Colorado 80045-2517
Retina Consultants of Southern Colorado PC Colorado Springs Colorado 80909
Retina Specialists of Colorado Denver Colorado 80222
Advanced Vision Research Institute Longmont Colorado 80503-6499
Retina Group of New England Waterford Connecticut 06385-1215
National Ophthalmic Research Institute Fort Myers Florida 33912
Florida Retina Institute Jacksonville Florida 32216-6347
Retina Associates of Florida;Retina Associates of Florida Tampa Florida 33609
Southeast Retina Center Augusta Georgia 30909-6440
Georgia Retina PC Marietta Georgia 30060
Retina Consultants of Hawaii ‘Aiea Hawaii 96701
Illinois Eye and Ear Infirmary Chicago Illinois 60612
University Retina and Macula Associates, PC Oak Forest Illinois 60452
Raj K. Maturi, MD PC Indianapolis Indiana 46290
The Retina Care Center Baltimore Maryland 21209
Johns Hopkins Hospital Baltimore Maryland 21287
Retina Group of Washington Chevy Chase Maryland 20815
Cumberland Valley Retina Consultants Hagerstown Maryland 21740
Chesapeake Retina Centers - Waldorf Waldorf Maryland 20602
Associated Retinal Consultants - Royal Oak Royal Oak Michigan 48073
Retina Consultants Minnesota Saint Louis Park Minnesota 55416
Long Island Vitreoretinal Consultants;Opthalmology Hauppauge New York 11788
Retina Vitreous Surgeons of CNY PC Liverpool New York 13088
Opthalmic Consultants of LI Lynbrook New York 11563
Western Carolina Retinal Associate PA Asheville North Carolina 28803
North Carolina Retina Associates Cary North Carolina 27511
Duke University Medical Center Durham North Carolina 27705
Graystone Eye Hickory North Carolina 28602
North Carolina (NC) Retina Associates - Wake Forest Office Wake Forest North Carolina 27587-3803
Piedmont Retina Specialists Winston-Salem North Carolina 27103-6970
Cincinnati Eye Institute Blue Ash Ohio 45242-5537
University Hospitals Cleveland Medical Center Cleveland Ohio 44016
Ohio State Eye and Ear Institute Columbus Ohio 43212
Tulsa Retina Consultants Tulsa Oklahoma 74114
Cascade Medical Research Institute LLC Springfield Oregon 97477
Erie Retina Research Erie Pennsylvania 16505
Wills Eye Hospital Philadelphia Pennsylvania 19107-5109
Sewickely Eye Group Sewickley Pennsylvania 15143
Palmetto Retina Center West Columbia South Carolina 29169-2429
Charles Retina Institute Germantown Tennessee 38138
Retina Research Institute of Texas Abilene Texas 79606
Texas Retina Associates Arlington Texas 76012
Austin Retina Associates Austin Texas 78705
Austin Clinical Research LLC Austin Texas 78750
Retina & Vitreous of Texas Bellaire Texas 77401
Texas Retina Associates Dallas Texas 75231
Valley Retina Institute P.A. McAllen Texas 78550-9207
Medical Center Ophthalmology Associates San Antonio Texas 78240
Retina Consultants of Texas - San Antonio San Antonio Texas 78240
Brown Retina Institute San Antonio Texas 78251-4551
Retina Consultants of Texas The Woodlands Texas 77384
Strategic Clinical Research Group, LLC Willow Park Texas 76087
Retina Associates of Utah, PLLC;Clinical Research Salt Lake City Utah 84107
Piedmont Eye Center Lynchburg Virginia 24502-4271
Wagner Kapoor Institute Norfolk Virginia 23502
Virginia Eye Institute - Richmond - 7301 Forest Ave Richmond Virginia 23230
Retina Institute of Virginia Richmond Virginia 23235-1962
Spokane Eye Clinical Research Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06850922, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2026 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06850922 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →